This document outlines the steps for investigating an epidemic:
1) Verify diagnoses of cases and confirm the epidemic exceeds expected occurrences.
2) Define the at-risk population by mapping the area and counting residents.
3) Rapidly identify all cases through medical surveys and ask cases about other potential cases.
4) Analyze collected data on time, place, and person to identify common factors and form a hypothesis about the source and transmission of the disease.
The unusual occurrence in a community or region of disease, specific health related behaviour (eg. Smoking) or other health related events (eg. Traffic accidents) clearly in excess of “expected occurrence.
To define the magnitude of the epidemic outbreak or Involvement in terms of time, place and person.
To determine the particular conditions and factor responsible for the occurrence of the epidemic.
To identify the cause, source(s) of infection, and modes of transmission to determine measures necessary to control the epidemic; and
To make recommendations to prevent recurrence.
Verification of diagnosis
Confirmation of the existence of an epidemic
Defining the population at-risk
Rapid search for all cases and their characteristics
Data analysis
6) Formulation of hypotheses
7) Testing of hypotheses
8) Evaluation of ecological factors
9) Further investigation of population at risk
10) Writing the report
The unusual occurrence in a community or region of disease, specific health related behaviour (eg. Smoking) or other health related events (eg. Traffic accidents) clearly in excess of “expected occurrence.
To define the magnitude of the epidemic outbreak or Involvement in terms of time, place and person.
To determine the particular conditions and factor responsible for the occurrence of the epidemic.
To identify the cause, source(s) of infection, and modes of transmission to determine measures necessary to control the epidemic; and
To make recommendations to prevent recurrence.
Verification of diagnosis
Confirmation of the existence of an epidemic
Defining the population at-risk
Rapid search for all cases and their characteristics
Data analysis
6) Formulation of hypotheses
7) Testing of hypotheses
8) Evaluation of ecological factors
9) Further investigation of population at risk
10) Writing the report
Investigation of an epidemic by taking ebola as an example...Grandhe Sumanth
investigation of an epidemic by taking ebola as an example....................................................................................................................................................................................................................................................................
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Investigation of an epidemic by taking ebola as an example...Grandhe Sumanth
investigation of an epidemic by taking ebola as an example....................................................................................................................................................................................................................................................................
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
1. Definition:
• The “unusual” occurrence in a community or
region of disease ,specific health-related
behaviour (smoking) or other health-related
events (traffic accidents) clearly in excess
of “expected occurrence”.
• It implies an imbalance between agent, host &
environment.
2. Objectives of epidemic
investigation:
• Define magnitude of epidemic outbreak
• Determine particular conditions
responsible for outbreak of epidemic
• Identify cause, source & mode of
transmission to determine measures
necessary for control of epidemic
• Make recommendations for preventing
recurrence
3. 1. Verification of diagnosis:
• First step in epidemic investigation.
• Clinical examination of a sample of cases is useful.
• Laboratory investigation are used for
confirmation of diagnosis.
4. 2. Confirmation of the existence of an
epidemic:
•Compare the disease frequency during the
same period of previous year.
•An epidemic is said to exist when the number
of cases is in excess of the expected frequency
for that population, based on past experience.
5. 3. Defining population at risk:
Obtaining a map of the area:
Map of the area with natural landmarks, roads
& dwelling units should be prepared.
Area should be divided into segments, using
natural landmarks as boundaries.
Counting the population:
entire population of the given area according
to age, sex are carried out by house to house
survey.
6. 4. Rapid search for all cases &
their characteristics
• Medical survey should be carried out in the
defined area to identify all cases including
those who have not sought medical care.
• Epidemiological case sheet with data
collected from cases & from persons
apparently exposed but unaffected should be
prepared.
• Searching for more cases by asking patient
if he knew anyone in house or surroundings
with similar symptoms.
7. 5. Data analysis:
• Data collected should be analyzed using
the classical epidemiological parameters
time, place & person.
• Purpose of data analysis is to identify
common event or experience & to delineate
the group involved in the common
experience.
8. TIME:
• Prepare chronological distribution of dates
& construct an epidemic curve
• Look for time clustering of cases
9. An epidemic curve suggests
• Time relation with exposure to a
suspected source.
• whether it is a common source or a
propagated epidemic.
• Whether it is a seasonal or cyclic pattern
suggestive of a particular infection.
10. PLACE:
• Prepare a spot map of cases with their
relation to possible source of infection.
Ex: water supply, air pollution, foods eaten,
occupation etc.
• Clustering of cases indicates common
source of infection.
PERSON:
• Analyze the data by age, sex, occupation &
other possible risk factors.
12. 6. Formulation of hypothesis:
• On the basis of time, place & person
distribution or the agent-host-environment
model, formulate hypothesis.
• This explains epidemic in terms of
a) Possible source
b) Causative agent
c) Possible modes of spread
d) Environmental factors which enabled to
occur
13. 7. Testing of hypothesis:
• All reasonable hypotheses need to be
considered & weighed by comparing the
attack rates in various groups for those
exposed & those not exposed ,to each
suspected factor.
This will enable the epidemiologist to
ascertain which hypothesis is consistent
with all the known facts.
14. 8. Evaluation of ecological factors:
• Circumstances involved in transmission of
diseases should be investigated to prevent
further transmission of disease.
• Ecological factors that have made the epidemic
possible should be investigated.
• Primary concern of the epidemiologist is to
relate the disease to environmental factors, to
know the source of infection, reservoirs &
modes of transmission.
15. 9. Further investigation of
population at risk
• Population at risk should be studied to obtain
further information.
• This may involve medical examination, screening
tests, examination of suspected food, faeces,
or blood samples, biochemical studies,
assessment of immunity status, etc.
• This permits classification of all members as to
a) exposure to specific potential vehicle.
b) whether ill or not
16. 10. Writing the report:
1.Background:
geographical location
climatic conditions
demographic status (population
pyramid)
socioeconomic situation
organization of health services
surveillance & early warning systems
normal disease prevalence
17. 2.Historical data:
a) previous occurrence of epidemics
of the same disease
locally or elsewhere
b) occurrence of related disease, if any
in the same area
in other areas
c) discovery of the first case of
present outbreak
18. 3.Methodology of investigation:
case definition
questionnaire used in epidemiological
investigation
survey teams
house hold survey
retrospective survey
prospective surveillance
collection of laboratory specimens
laboratory techniques
19. 4. Analysis of data:
a) clinical data
frequency of signs & symptoms
course of disease
differential diagnosis
death or sequelae rates
b) epidemiological data
mode of occurrence
in time, by place &population groups
20. c) modes of transmission
source of infection
routes of excretion & portal of entry
factors influencing transmission
d) laboratory data
isolation of agents
serological confirmation
significance of results
21. e) interpretation of data
comprehensive picture of the out
break.
hypotheses as to cause.
formulation & testing of hypotheses by
statistical analysis.
22. 5. Control measures:
a) definition of strategies & methodology
of implementation
-constrains &
-results
b) evaluation:
-significance of results
-cost / effectiveness
c) preventive measures